Estrogen/elcometrine contraceptive sprays - Acrux

Drug Profile

Estrogen/elcometrine contraceptive sprays - Acrux

Alternative Names: Combination contraceptive sprays - Acrux; Duomist; Estrogen/Nestorone® contraceptive sprays; Estrogen/progestogen contraceptive sprays; Estrogens/elcometrine; Ethinylestradiol/elcometrine

Latest Information Update: 23 Feb 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Acrux
  • Class Hormonal contraceptives; Hormonal replacements
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Pregnancy

Most Recent Events

  • 12 Jun 2014 Discontinued - Phase-I for Contraception/Pregnancy (Prevention) in Australia (Transdermal)
  • 29 May 2014 KV Pharmaceutical is now called Lumara Health
  • 14 Aug 2008 Phase I development is ongoing in Australia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top